City

Bay City (1)

Detroit (1)

Rochester (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Barbara Ann Karmanos Cancer Institute (1)

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

laboratory biomarker analysis (3)

auranofin (1)

dexamethasone (1)

hsp90 inhibitor at13387 (1)

pharmacological study (1)

sirolimus (1)

talazoparib (1)

valproic acid (1)

Study Documents

Intervention Type

drug (3)

other (3)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

ovarian serous tumor

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ovarian Serous Tumor, Recurrent Ovarian Carcinoma Trial in Rochester (Auranofin, Laboratory Biomarker Analysis, Sirolimus)

Active, not recruiting

Ovarian Serous Tumor
Recurrent Ovarian Carcinoma

Auranofin
+2 more

Rochester, Minnesota

Mayo Clinic

Mar 22, 2022

Adnexal Mass, Borderline Ovarian Epithelial Tumor, Ovarian Clear Cell Tumor Trial in Bay City, Detroit (Dexamethasone,

Completed

Adnexal Mass
+6 more

Dexamethasone
+2 more

Bay City, Michigan
+1 more

Aug 12, 2019

Adult Solid Tumor, Estrogen Receptor Negative, Fallopian Tube Serous Tumor Trial (Hsp90 Inhibitor AT13387, Laboratory Biomarker

Withdrawn

Adult Solid Neoplasm
+12 more

Hsp90 Inhibitor AT13387
+3 more

(no location specified)

Jul 22, 2016